| ￥3300 | |
| Z05117-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human | |
| Protein Construction |
|
|
| Purity | > 95% as determined by Bis-Tris PAGE | |
| Endotoxin Level | Less than 1EU per μg by the LAL method. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 8.91 kDa | |
| Apparent Molecular Weight | The protein migrates to 12-14 kDa based on Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22μm filtered solution in PBS (pH 7.4). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable up to 6 months at -20 °C or below. Upon reconstitution, the product should be stable for 3 months at -80 °C. Avoid repeated freeze-thaw cycles. |
CCL8, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | C-C motif Chemokine ligand 8 (CCL8) has been found in diseases' pathogenesis. Exogenous CCL8 enhanced the proliferative and migration potential of LE cells and their motility in the environment with its stable concentration.of all the examined factors, chemokine CCL8 participates in the establishment of a proper environment for embryo implantation. |
| Synonyms | HC14; MCP-2; MCP2; SCYA10; SCYA8 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
